Quantum Discovery Labs » toxicity http://q-pharm.com The drug discovery company Fri, 03 Feb 2012 10:47:43 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 Does size matter? http://q-pharm.com/2010/04/does-size-matter/ http://q-pharm.com/2010/04/does-size-matter/#comments Fri, 23 Apr 2010 09:37:58 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=220
  • How drug-like are vendor libraries?
  • How good are biological data – II: Trombine, GSK, GPCR
  • High Throughput Screening of Transcription factor DLX5
  • Protein Flexibility and False Positives detection.
  • Docking validation study: classic example, thrombine
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2010/04/does-size-matter/feed/ 1     Do we need those nM-inhibitors? http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/ http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/#comments Wed, 11 Nov 2009 13:46:28 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=122
  • Does size matter?
  • New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1
  • From Biological Spectra (multiple protein binding data) to pharmacological profiling!
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/feed/ 1     How drug-like are vendor libraries? http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/ http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/#comments Mon, 26 Oct 2009 17:24:24 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=63
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/feed/ 0     From Biological Spectra (multiple protein binding data) to pharmacological profiling! http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/ http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/#comments Thu, 25 Sep 2008 12:53:00 +0000 fedichev http://q-pharm.com/?p=39
  • From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
  • How good are biological experiments? HERG binding data analysis
  • QUANTUM and HSA binding calculations: the role of protein flexibility
  • How good are biological data – II: Trombine, GSK, GPCR
  • LD50 vs. MRDD: what’s death for a mice is good enough for a man
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/feed/ 0     LD50 vs. MRDD: what’s death for a mice is good enough for a man http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/ http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/#comments Thu, 24 Jan 2008 20:00:00 +0000 fedichev http://q-pharm.com/?p=24
  • Toxicity Prediction
  • From Biological Spectra (multiple protein binding data) to pharmacological profiling!
  • Do we need those nM-inhibitors?
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
  • 2008 Quantum’s technology platform update and software releases
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/feed/ 0